NewsBenzingaXenetic Biosciences anuncia que su socio colaborador PeriNess administra la primera dosis al primer participante en el ensayo clínico de DNasa humana recombinante sistémica para tratar el linfoma de células B grandes en Israel Xenetic Biosciences anuncia que su socio colaborador PeriNess administra la primera dosis al primer participante en el ensayo clínico de DNasa humana recombinante sistémica para tratar el linfoma de células B grandes en Israel Benzinga 2026.10.15 12:49 (GMT+0) Open on Benzinga Other news Jensen Huang's GTC Berlin Keynote: NVIDIA Shifts from "Selling GPUs" to "Selling AI Factories," Vera Rubin Enters Full Production Anthropic releases new Claude API version, removing sampling parameters like temperature Tesla Doesn’t Sell a Single Bitcoin in Q3 as Crypto Stash Jumps 42% to $962 Million South Korea's IT and cybersecurity industry urgently responding to critical PHP vulnerability Ethereum spot ETFs saw $14.955 million in total net inflows yesterday, turning to net inflows after 5 consecutive days of net outflows Bitcoin spot ETFs saw $528 million in total net inflows yesterday, marking 3 consecutive days of net inflows
Jensen Huang's GTC Berlin Keynote: NVIDIA Shifts from "Selling GPUs" to "Selling AI Factories," Vera Rubin Enters Full Production
Ethereum spot ETFs saw $14.955 million in total net inflows yesterday, turning to net inflows after 5 consecutive days of net outflows
Bitcoin spot ETFs saw $528 million in total net inflows yesterday, marking 3 consecutive days of net inflows
